Icahn Enterprises L P IEP

NAS: IEP | ISIN: US4511001012   28/03/2024
17,01 USD (+0,06%)
(+0,06%)   28/03/2024

Icahn Enterprises L.P. Reports Fourth Quarter 2022 Financial Results

  • For the twelve months ended December 31, 2022, net loss attributable to Icahn Enterprises was $183 million, or $0.57 per depositary unit. For the twelve months ended December 31, 2021, net loss attributable to Icahn Enterprises was $518 million, or $2.32 per depositary unit. For the twelve months ended December 31, 2022, Adjusted EBITDA attributable to Icahn Enterprises was $758 million compared to $273 million for the twelve months ended December 31, 2021
  • Fourth quarter net loss attributable to IEP was $255 million with Adjusted EBITDA loss attributable to IEP of $54 million. This is an improvement over prior year fourth quarter results of $141 million in net loss and $389 million Adjusted EBITDA
  • Indicative Net Asset Value increased by $522 million to $5.6 billion as of December 31, 2022 compared to December 31, 2021. The change in indicative net asset value includes, among other things, changes in the fair value of certain subsidiaries which are not included in our GAAP earnings
  • Board approves quarterly distribution of $2.00 per depositary unit (the 71st consecutive quarterly distribution since 2005) 

SUNNY ISLES BEACH, Fla., Feb. 24, 2023 /PRNewswire/ -- Icahn Enterprises L.P. (Nasdaq:IEP) is reporting revenues of $14.1 billion and net loss attributable to Icahn Enterprises of $183 million, or $0.57 per depositary unit, for the twelve months ended December 31, 2022. For the twelve months ended December 31, 2021, revenues were $11.3 billion and net loss attributable to Icahn Enterprises was $518 million, or $2.32 per depositary unit. Adjusted EBITDA attributable to Icahn Enterprises was $758 million for the twelve months ended December 31, 2022, compared to $273 million for the twelve months ended December 31, 2021.   

Fourth quarter 2022 revenues were $3.1 billion and net loss attributable to Icahn Enterprises was $255 million, or a loss of $0.74 per depositary unit. For the three months ended December 31, 2021, revenues were $2.3 billion and net loss attributable to Icahn Enterprises was $396 million, or a loss of $1.72 per depositary unit. For the three months ended December 31, 2022, Adjusted EBITDA attributable to Icahn Enterprises was a loss of $54 million compared to a loss of $443 million for the three months ended December 31, 2021.   

For the twelve months ended December 31, 2022, indicative net asset value increased by $522 million to $5.6 billion. The change in indicative net asset value includes, among other things, changes in the fair value of certain subsidiaries which are not included in our GAAP earnings reported above.   

On February 22, 2023, the Board of Directors of the general partner of Icahn Enterprises declared a quarterly distribution in the amount of $2.00 per depositary unit, which will be paid on or about April 19, 2023, to depositary unitholders of record at the close of business on March 13, 2023. Depositary unitholders will have until April 6, 2023, to make a timely election to receive either cash or additional depositary units. If a unitholder does not make a timely election, it will automatically be deemed to have elected to receive the distribution in additional depositary units. Depositary unitholders who elect to receive (or who are deemed to have elected to receive) additional depositary units will receive units valued at the volume weighted average trading price of the units during the five consecutive trading days ending April 14, 2023. Icahn Enterprises will make a cash payment in lieu of issuing fractional depositary units to any unitholders electing to receive (or who are deemed to have elected to receive) depositary units.  

 ***

Icahn Enterprises L.P., a master limited partnership, is a diversified holding company owning subsidiaries currently engaged in the following continuing operating businesses: Investment, Energy, Automotive, Food Packaging, Real Estate, Home Fashion and Pharma.

Caution Concerning Forward-Looking Statements

This release may contain certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, many of which are beyond our ability to control or predict. Forward-looking statements may be identified by words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," "will" or words of similar meaning and include, but are not limited to, statements about the expected future business and financial performance of Icahn Enterprises and its subsidiaries. Actual events, results and outcomes may differ materially from our expectations due to a variety of known and unknown risks, uncertainties and other factors, including risks related to economic downturns, substantial competition and rising operating costs; risks related to the severity, magnitude and duration of the COVID-19 pandemic and its impact on the global economy, financial markets and industries in which our subsidiaries operate; the impacts from the Russia/Ukraine conflict, including economic volatility and the impacts of export controls and other economic sanctions; risks related to our investment activities, including the nature of the investments made by the private funds in which we invest, declines in the fair value of our investments as a result of the COVID-19 pandemic, losses in the private funds and loss of key employees; risks related to our ability to continue to conduct our activities in a manner so as to not be deemed an investment company under the Investment Company Act of 1940, as amended; risks related to our energy business, including the volatility and availability of crude oil, other feed stocks and refined products, declines in global demand for crude oil, refined products and liquid transportation fuels as a result of the COVID-19 pandemic, unfavorable refining margin (crack spread), interrupted access to pipelines, significant fluctuations in nitrogen fertilizer demand in the agricultural industry and seasonality of results; risks related to our automotive activities and exposure to adverse conditions in the automotive industry, including as a result of the COVID-19 pandemic; risks related to our food packaging activities, including competition from better capitalized competitors, inability of our suppliers to timely deliver raw materials, and the failure to effectively respond to industry changes in casings technology; supply chain issues; inflation, including increased costs of raw materials and shipping, including as a result of the Russia/Ukraine conflict; interest rate increases; labor shortages and workforce availability; risks related to our real estate activities, including the extent of any tenant bankruptcies and insolvencies; risks related to our home fashion operations, including changes in the availability and price of raw materials, and changes in transportation costs and delivery times; and other risks and uncertainties detailed from time to time in our filings with the Securities and Exchange Commission. Additionally, there may be other factors not presently known to us or which we currently consider to be immaterial that may cause our actual results to differ materially from the forward-looking statements. Past performance in our Investment segment is not indicative of future performance. We undertake no obligation to publicly update or review any forward-looking information, whether as a result of new information, future developments or otherwise. 


CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)
















Three Months Ended December 31, 


Year Ended December 31, 



2022


2021


2022


2021



(in millions, except per unit amounts)

Revenues:













Net sales


$

3,280


$

2,817


$

13,378


$

10,304

Other revenues from operations



186



161



748



647

Net (loss) gain from investment activities



(478)



(842)



(168)



193

Interest and dividend income



148



43



328



137

(Loss) gain on disposition of assets, net



(11)



165



(8)



141

Other loss, net



(24)



(29)



(177)



(84)




3,101



2,315



14,101



11,338

Expenses:













Cost of goods sold



2,951



2,673



11,689



9,485

Other expenses from operations



142



141



583



522

Selling, general and administrative



329



308



1,250



1,238

Restructuring, net



2



(1)



2



5

Interest expense



144



155



568



666




3,568



3,276



14,092



11,916

(Loss) income before income tax benefit (expense)



(467)



(961)



9



(578)

Income tax benefit (expense)



59



135



(34)



78

Net loss



(408)



(826)



(25)



(500)

Less: net (loss) income attributable to non-controlling interests



(153)



(430)



158



18

Net loss attributable to Icahn Enterprises


$

(255)


$

(396)


$

(183)


$

(518)














Net (loss) income attributable to Icahn Enterprises allocated to:













Limited partners


$

(250)


$

(484)


$

(179)


$

(604)

General partner



(5)



88



(4)



86



$

(255)


$

(396)


$

(183)


$

(518)














Basic and diluted loss per LP unit


$

(0.74)


$

(1.72)


$

(0.57)


$

(2.32)

Basic and diluted weighted average LP units outstanding



340



281



316



260

Distributions declared per LP unit


$

2.00


$

2.00


$

8.00


$

8.00




CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)










December 31, 


December 31, 



2022


2021



(in millions)

ASSETS







Cash and cash equivalents


$

2,337


$

2,321

Cash held at consolidated affiliated partnerships and restricted cash



2,549



2,115

Investments



6,809



9,151

Due from brokers



7,044



5,530

Accounts receivable, net



606



546

Inventories, net



1,531



1,478

Property, plant and equipment, net



4,038



4,085

Derivative assets, net



812



612

Goodwill



288



290

Intangible assets, net



533



595

Other assets



1,367



1,023

Total Assets


$

27,914


$

27,746

LIABILITIES AND EQUITY







Accounts payable


$

870


$

805

Accrued expenses and other liabilities



1,981



1,778

Deferred tax liabilities



338



390

Derivative liabilities, net



691



787

Securities sold, not yet purchased, at fair value



6,495



5,340

Due to brokers



885



1,611

Debt



7,096



7,692

Total liabilities



18,356



18,403








Equity:







Limited partners



4,647



4,298

General partner



(747)



(754)

Equity attributable to Icahn Enterprises



3,900



3,544

Equity attributable to non-controlling interests



5,658



5,799

Total equity



9,558



9,343

Total Liabilities and Equity


$

27,914


$

27,746

 

Use of Non-GAAP Financial Measures

The Company uses certain non-GAAP financial measures in evaluating its performance. These include non-GAAP EBITDA and Adjusted EBITDA. EBITDA represents earnings from continuing operations before interest expense, income tax (benefit) expense and depreciation and amortization. We define Adjusted EBITDA as EBITDA excluding certain effects of impairment, restructuring costs, certain pension plan expenses, gains/losses on disposition of assets, gains/losses on extinguishment of debt and certain other non-operational charges. We present EBITDA and Adjusted EBITDA on a consolidated basis and on a basis attributable to Icahn Enterprises net of the effects of non-controlling interests. We conduct substantially all of our operations through subsidiaries. The operating results of our subsidiaries may not be sufficient to make distributions to us. In addition, our subsidiaries are not obligated to make funds available to us for payment of our indebtedness, payment of distributions on our depositary units or otherwise, and distributions and intercompany transfers from our subsidiaries to us may be restricted by applicable law or covenants contained in debt agreements and other agreements to which these subsidiaries currently may be subject or into which they may enter into in the future. The terms of any borrowings of our subsidiaries or other entities in which we own equity may restrict dividends, distributions or loans to us. 

We believe that providing EBITDA and Adjusted EBITDA to investors has economic substance as these measures provide important supplemental information of our performance to investors and permits investors and management to evaluate the core operating performance of our business without regard to interest, taxes and depreciation and amortization and certain effects of impairment, restructuring costs, certain pension plan expenses, gains/losses on disposition of assets, gains/losses on extinguishment of debt and certain other non-operational charges. Additionally, we believe this information is frequently used by securities analysts, investors and other interested parties in the evaluation of companies that have issued debt. Management uses, and believes that investors benefit from referring to, these non-GAAP financial measures in assessing our operating results, as well as in planning, forecasting and analyzing future periods. Adjusting earnings for these charges allows investors to evaluate our performance from period to period, as well as our peers, without the effects of certain items that may vary depending on accounting methods and the book value of assets. Additionally, EBITDA and Adjusted EBITDA present meaningful measures of performance exclusive of our capital structure and the method by which assets were acquired and financed. 

EBITDA and Adjusted EBITDA have limitations as analytical tools, and you should not consider them in isolation, or as substitutes for analysis of our results as reported under generally accepted accounting principles in the United States, or U.S. GAAP. For example, EBITDA and Adjusted EBITDA: 

  • do not reflect our cash expenditures, or future requirements for capital expenditures, or contractual commitments; 
  • do not reflect changes in, or cash requirements for, our working capital needs; and 
  • do not reflect the significant interest expense, or the cash requirements necessary to service interest or principal payments on our debt. 

Although depreciation and amortization are non-cash charges, the assets being depreciated or amortized often will have to be replaced in the future, and EBITDA and Adjusted EBITDA do not reflect any cash requirements for such replacements. Other companies in the industries in which we operate may calculate EBITDA and Adjusted EBITDA  differently than we do, limiting their usefulness as comparative measures. In addition, EBITDA and Adjusted EBITDA  do not reflect the impact of earnings or charges resulting from matters we consider not to be indicative of our ongoing operations. 

EBITDA and Adjusted EBITDA are not measurements of our financial performance under U.S. GAAP and should not be considered as alternatives to net income or any other performance measures derived in accordance with U.S. GAAP or as alternatives to cash flow from operating activities as a measure of our liquidity. Given these limitations, we rely primarily on our U.S. GAAP results and use EBITDA and Adjusted EBITDA only as a supplemental measure of our financial performance. 

Use of Indicative Net Asset Value Data

The Company uses indicative net asset value as an additional method for considering the value of the Company's assets, and we believe that this information can be helpful to investors. Please note, however, that the indicative net asset value does not represent the market price at which the depositary units trade. Accordingly, data regarding indicative net asset value is of limited use and should not be considered in isolation. 

The Company's depositary units are not redeemable, which means that investors have no right or ability to obtain from the Company the indicative net asset value of units that they own. Units may be bought and sold on The Nasdaq Global Select Market at prevailing market prices. Those prices may be higher or lower than the indicative net asset value of the depositary units as calculated by management. 

See below for more information on how we calculate the Company's indicative net asset value. 






December 31, 


December 31,


2022


2021


(in millions)(unaudited)

Market-valued Subsidiaries and Investments:




   Holding Company interest in Investment Funds(1)

$ 4,184


$ 4,271

   CVR Energy(2)

2,231


1,197

   Delek(2)

-


105

Total market-valued subsidiaries and investments

$ 6,415


$ 5,573





Other Subsidiaries:




   Viskase(3)

$ 243


$ 230

   Real Estate Holdings(1)

455


472

   WestPoint Home(1)

156


132

   Vivus(1)

241


259





   Automotive Services(4)

490


952

   Automotive Parts(1)

381


422

   Automotive Owned Real Estate Assets(5)

831


1,187

   Icahn Automotive Group

1,702


2,561





Total other subsidiaries

$ 2,797


$ 3,654

   Add: Other Holding Company net assets(6)

20


(3)

Indicative Gross Asset Value

$ 9,232


$ 9,224

   Add: Holding Company cash and cash equivalents(7)

1,720


1,707

   Less: Holding Company debt(7)

(5,309)


(5,810)

Indicative Net Asset Value

$ 5,643


$ 5,121

 

Indicative net asset value does not purport to reflect a valuation of IEP. The calculated indicative net asset value does not include any value for our Investment Segment other than the fair market value of our investment in the Investment Funds. A valuation is a subjective exercise and indicative net asset value does not necessarily consider all elements or consider in the adequate proportion the elements that could affect the valuation of IEP. Investors may reasonably differ on what such elements are and their impact on IEP. No representation or assurance, express or implied, is made as to the accuracy and correctness of indicative net asset value as of these dates or with respect to any future indicative or prospective results which may vary. 

(1)

Represents GAAP equity attributable to us as of each respective date.

(2)

Based on closing share price on each date (or if such date was not a trading day, the immediately preceding trading day) and the number of shares owned by the Holding Company as of each respective date. 

(3)

Amounts based on market comparables due to lack of material trading volume, valued at 9.0x Adjusted EBITDA for the twelve months ended December 31, 2022 and December 31, 2021. 

(4)

Amounts based on market comparables due to lack of material trading volume, valued at 14.0x Adjusted EBITDA for the twelve months ended December 31, 2022 and December 31, 2021.  

(5)

Management performed a valuation on the owned real-estate with the assistance of third-party consultants to estimate fair-market-value. This analysis utilized property-level market rents, location level profitability, and utilized prevailing cap rates ranging from 6.8% to 8.0% as of December 31, 2022, and 5.5% to 6.5% as of December 31, 2021. The valuation assumed that triple net leases are in place for all the locations at rents estimated by management based on market conditions. There is no assurance we would be able to sell the assets on the timeline or at the prices and lease terms we estimate. Different judgments or assumptions would result in different estimates of the value of these real estate assets. Moreover, although we evaluate and provide our Indicative Net Asset Value on a regular basis, the estimated values may fluctuate in the interim, so that any actual transaction could result in a higher or lower valuation. 

(6)

Holding Company's balance as of each respective date, excluding non-cash deferred tax assets or liabilities. 

(7)

Holding Company's balance as of each respective date.










Three Months Ended December 31, 


Year Ended December 31, 


2022


2021


2022


2021


(in millions)(unaudited)

Adjusted EBITDA








   Net loss

($408)


($826)


($25)


($500)

   Interest expense, net

121


153


528


661

   Income tax (benefit) expense

(59)


(135)


34


(78)

   Depreciation and amortization

129


132


509


517

EBITDA before non-controlling interests

(217)


(676)


1,046


600

   Restructuring costs

2


1


2


1

   Loss (gain) on disposition of assets, net

1


(165)


(3)


(144)

   Transformation losses

12


34


53


149

   Net loss on extinguishment of debt

-


-


1


5

Out of period adjustments

52


-


52


-

Call option lawsuits settlement

-


-


79


-

   Other

29


5


40


2

Adjusted EBITDA before non-controlling interests

($121)


($801)


$ 1,270


$ 613









Adjusted EBITDA attributable to IEP








   Net (loss)

($255)


($396)


($183)


($518)

   Interest expense, net

87


114


393


480

   Income tax (benefit) expense

(72)


(128)


(4)


(66)

   Depreciation and amortization

90


92


352


367

EBITDA attributable to IEP

(150)


(318)


558


263

   Restructuring costs

2


1


2


1

   Loss (gain) on disposition of assets, net

1


(165)


(3)


(144)

   Transformation losses

12


34


53


149

   Net loss on extinguishment of debt

-


-


1


3

Out of period adjustments

52


-


52


-

Call option lawsuits settlement

-


-


56


-

   Other

29


5


39


1

Adjusted EBITDA attributable to IEP

($54)


($443)


$ 758


$ 273

 

Investor Contact:
Ted Papapostolou, Chief Financial Officer
(305) 422-4100

 

Cision View original content:https://www.prnewswire.com/news-releases/icahn-enterprises-lp-reports-fourth-quarter-2022-financial-results-301755201.html

SOURCE Icahn Enterprises L.P.

Icahn Enterprises L P in het nieuws

Mijn selecties